Melbourne, Feb 16, 2009 (ABN Newswire) - Mesoblast Limited (ASX:MSB)(PINK:MBLTY) One of Singapore’s leading private healthcare providers, Parkway Group Healthcare Pte Ltd, a subsidiary of Parkway Holdings Limited, and Australian regenerative medicine company, Mesoblast Limited, today announced a collaborative program to facilitate commercialisation of Mesoblast’s proprietary “off-the-shelf” stem cell products within the extensive ParkwayHealth hospital network in Asia.
